FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology. Presented is vaccine composition for vaccination against influenza infection and kit for vaccination against influenza infection, containing vaccine composition. Vaccine composition contains an effective amount of at least one complex ISCOM matrix and effective amount of at least one ecto domain of haemagglutinin domain and at least one ecto domain from neuraminidase domain. At that, ecto domains are ecto domains, extracted from influenza virus.
EFFECT: presented vaccine composition and kit can be used in medicine as alternative version of existing vaccines against influenza viruses, as improving immune response due to application of complex ISCOM matrix.
14 cl, 6 dwg, 1 tbl 3 ex
Title | Year | Author | Number |
---|---|---|---|
POLYVALENT VACCINE AGAINST INFLUENZA BASED ON NANOPARTICLES | 2019 |
|
RU2805552C2 |
VACCINE COMPOSITIONS CHARACTERIZED BY IMPROVED STABILITY AND IMMUNOGENICITY | 2016 |
|
RU2730625C2 |
ATTENUATED GRIPPOSE VECTOR AND MUCOSAL UNIVERSAL GRIPPOSE VACCINE ON ITS BASIS | 2016 |
|
RU2660562C2 |
NEW ADJUVANT COMPOSITIONS | 2009 |
|
RU2510280C2 |
BROAD-SPECTRUM M2 PROTEIN ECTODOMAIN AVIAN INFLUENZA TYPE A VACCINE | 2014 |
|
RU2571944C1 |
VACCINE COMPOSITION FOR NON-IMMUNISED INDIVIDUALS | 2013 |
|
RU2661407C2 |
COMPUTER-OPTIMIZED ANTIGENS WITH WIDE REACTIVITY SPECTRUM FOR INFLUENZA VIRUSES OF H5N1 AND H1N1 | 2013 |
|
RU2639551C2 |
H1N1 INFLUENZA VIRUS ANTIGENS WITH WIDE SPECTRUM OF ACTIVITY, OPTIMIZED USING COMPUTER TOOLS | 2012 |
|
RU2612900C2 |
VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS | 2013 |
|
RU2661408C2 |
METHOD OF STIMULATION OF HUMORAL AND CELLULAR IMMUNITY RESPONSE TO TARGET ANTIGEN | 1996 |
|
RU2127605C1 |
Authors
Dates
2016-05-10—Published
2011-07-25—Filed